Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
26 01 2021
Historique:
received: 30 12 2020
revised: 19 01 2021
accepted: 21 01 2021
entrez: 3 2 2021
pubmed: 4 2 2021
medline: 12 2 2021
Statut: epublish

Résumé

COVID-19 is a severe acute respiratory syndrome (SARS) caused by a new coronavirus (CoV), SARS-CoV-2, which is closely related to SARS-CoV that jumped the animal-human species barrier and caused a disease outbreak in 2003. SARS-CoV-2 is a betacoronavirus that was first described in 2019, unrelated to the commonly occurring feline coronavirus (FCoV) that is an alphacoronavirus associated with feline infectious peritonitis (FIP). SARS-CoV-2 is highly contagious and has spread globally within a few months, resulting in the current pandemic. Felids have been shown to be susceptible to SARS-CoV-2 infection. Particularly in the Western world, many people live in very close contact with their pet cats, and natural infections of cats in COVID-19-positive households have been described in several countries. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from 11 European Countries, discusses the current status of SARS-CoV infections in cats. The review examines the host range of SARS-CoV-2 and human-to-animal transmissions, including infections in domestic and non-domestic felids, as well as mink-to-human/-cat transmission. It summarises current data on SARS-CoV-2 prevalence in domestic cats and the results of experimental infections of cats and provides expert opinions on the clinical relevance and prevention of SARS-CoV-2 infection in cats.

Identifiants

pubmed: 33530620
pii: v13020185
doi: 10.3390/v13020185
pmc: PMC7911697
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Boehringer Ingelheim
ID : na
Organisme : Virbac
ID : na

Références

Vaccines (Basel). 2020 Dec 17;8(4):
pubmed: 33348613
Emerg Infect Dis. 2004 Feb;10(2):179-84
pubmed: 15030680
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553059
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
Curr Biol. 2020 Apr 6;30(7):1346-1351.e2
pubmed: 32197085
J Virol. 2004 Apr;78(7):3572-7
pubmed: 15016880
Emerg Microbes Infect. 2020 Dec;9(1):2013-2019
pubmed: 32867625
Vet Rec. 2021 Apr;188(8):e247
pubmed: 33890314
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Emerg Infect Dis. 2004 Jul;10(7):1293-6
pubmed: 15324552
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Zoonoses Public Health. 2021 Feb;68(1):67-68
pubmed: 33230915
Lancet. 2003 Jul 26;362(9380):263-70
pubmed: 12892955
Pathogens. 2020 Sep 11;9(9):
pubmed: 32932800
Viruses. 2021 May 19;13(5):
pubmed: 34069453
Chin Med J (Engl). 2013;126(19):3790-2
pubmed: 24112184
N Engl J Med. 2003 May 15;348(20):1953-66
pubmed: 12690092
Vet Pathol. 2008 Jul;45(4):551-62
pubmed: 18587105
Emerg Infect Dis. 2020 Dec;26(12):3069-3071
pubmed: 32788033
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Science. 2003 Oct 10;302(5643):276-8
pubmed: 12958366
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24790-24793
pubmed: 32948692
DNA Cell Biol. 2005 Aug;24(8):485-90
pubmed: 16101345
Emerg Infect Dis. 2020 Dec;26(12):3071-3074
pubmed: 32938527
Viral Immunol. 2007 Spring;20(1):197-205
pubmed: 17425434
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
J Infect. 2020 Apr;80(4):469-496
pubmed: 32092392
N Engl J Med. 2003 May 15;348(20):1986-94
pubmed: 12682352
N Engl J Med. 2020 Aug 6;383(6):592-594
pubmed: 32402157
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
J Comp Pathol. 2014 Jul;151(1):83-112
pubmed: 24581932
Adv Virus Res. 2018;100:163-188
pubmed: 29551135
Nat Commun. 2020 Jul 8;11(1):3496
pubmed: 32641684
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
Emerg Infect Dis. 2005 Mar;11(3):446-8
pubmed: 15757562
N Engl J Med. 2003 May 15;348(20):1967-76
pubmed: 12690091
PLoS Med. 2006 May;3(5):e149
pubmed: 16605302
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):710-713
pubmed: 32525853
Med Microbiol Immunol. 2005 Jan;194(1-2):1-6
pubmed: 15118911
J Hosp Infect. 2005 Oct;61(2):107-11
pubmed: 15923059
Int J Environ Res Public Health. 2020 Mar 03;17(5):
pubmed: 32138266
Emerg Infect Dis. 2013 Oct;19(10):1697-9
pubmed: 24050621
Nature. 2020 Jul;583(7815):282-285
pubmed: 32218527
Nat Commun. 2020 Dec 4;11(1):6231
pubmed: 33277505
J Infect Dis. 2011 Jun 1;203(11):1574-81
pubmed: 21592986
Virus Res. 2008 Apr;133(1):74-87
pubmed: 17451830
Nature. 2003 May 15;423(6937):240
pubmed: 12748632
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
J Virol. 2005 May;79(9):5833-8
pubmed: 15827197
Transbound Emerg Dis. 2021 Mar;68(2):973-976
pubmed: 32810370
One Health. 2020 Dec;10:100164
pubmed: 32904469
Virol J. 2016 Jun 03;13:87
pubmed: 27255185
Nature. 2003 Oct 30;425(6961):915
pubmed: 14586458
J Pathol. 2005 Jul;206(3):251-9
pubmed: 15892035
Transbound Emerg Dis. 2020 Nov;67(6):2324-2328
pubmed: 32500944
J Feline Med Surg. 2020 Apr;22(4):350-357
pubmed: 31094626
One Health. 2021 Jun;11:100192
pubmed: 33169106
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382-26388
pubmed: 32994343
J Virol. 2005 Jan;79(1):503-11
pubmed: 15596843
Emerg Infect Dis. 2005 Dec;11(12):1860-5
pubmed: 16485471
Virology. 2004 Dec 5;330(1):8-15
pubmed: 15527829
J Virol. 2005 Feb;79(4):2620-5
pubmed: 15681462
J Virol. 2004 Oct;78(20):11401-4
pubmed: 15452262
Science. 2005 Oct 28;310(5748):676-9
pubmed: 16195424
Lancet. 2003 Apr 19;361(9366):1319-25
pubmed: 12711465
J Immunol. 2004 Sep 15;173(6):4030-9
pubmed: 15356152

Auteurs

Margaret J Hosie (MJ)

MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.

Regina Hofmann-Lehmann (R)

Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.

Katrin Hartmann (K)

Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany.

Herman Egberink (H)

Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, University of Utrecht, 3584 CL Utrecht, The Netherlands.

Uwe Truyen (U)

Institute of Animal Hygiene and Veterinary Public Health, University of Leipzig, 04103 Leipzig, Germany.

Diane D Addie (DD)

Maison Zabal, 64470 Etchebar, France.

Sándor Belák (S)

Department of Biomedical Sciences and Veterinary Public Health (BVF), Swedish University of Agricultural Sciences (SLU), Box 7036, 750 07 Uppsala, Sweden.

Corine Boucraut-Baralon (C)

Scanelis Laboratory, 31770 Colomiers, France.

Tadeusz Frymus (T)

Department of Small Animal Diseases with Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, 02-787 Warsaw, Poland.

Albert Lloret (A)

Fundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.

Hans Lutz (H)

Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.

Fulvio Marsilio (F)

Faculty of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy.

Maria Grazia Pennisi (MG)

Dipartimento di Scienze Veterinarie, Università di Messina, 98168 Messina, Italy.

Séverine Tasker (S)

Bristol Veterinary School, University of Bristol, Bristol BS40 5DU, UK.
Linnaeus Group, Shirley, Solihull B90 4BN, UK.

Etienne Thiry (E)

Veterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH Research Centre, Faculty of Veterinary Medicine, Liège University, B-4000 Liège, Belgium.

Karin Möstl (K)

Institute of Virology, Department for Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH